Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR).

Saved in:
Bibliographic Details
Title: Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR).
Authors: Tanaka A; Department of Cardiovascular Medicine, Saga University, Saga, Japan. tanakaa2@cc.saga-u.ac.jp., Vaduganathan M; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Imai T; Clinical Research Division, Organization for Clinical Medicine Promotion, Tokyo, Japan.; Clinical and Translational Research Center, Kobe University Hospital, Kobe, Japan., Okada Y; Clinical Research Center, Hospital of the University of Occupational and Environmental Health, Kitakyushu, Japan., Sonoda S; First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Torimoto K; First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Suwa S; Department of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan., Teragawa H; Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan., Miyazono M; Department of Nephrology, Saga University, Saga, Japan., Fukuda M; Department of Nephrology, Saga University, Saga, Japan., Yonezu K; Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan., Takahashi N; Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan., Yoshida Y; Department of Endocrinology, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Metabolism, Yufu, Japan., Tanaka K; Wakamatsu Hospital of the University of Occupational and Environmental Health, Kitakyushu, Japan., Shimabukuro M; Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan., Hotta Y; Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan., Moroi M; Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan., Niikura H; Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan., Kida K; Department of Pharmacology, St. Marianna University School of Medicine, Kawasaki, Japan., Yokota K; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan., Fukuda D; Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Tanabe K; Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan., Horiuchi Y; Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan., Toyoda S; Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan., Taguchi I; Department of Cardiology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan., Yoshida H; Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Miyoshi T; Department of Cardiovascular Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan., Shibata H; Department of Endocrinology, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Metabolism, Yufu, Japan., Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan. node@cc.saga-u.ac.jp.
Corporate Authors: FIVE-STAR Investigators
Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Dec 05; Vol. 24 (1), pp. 454. Date of Electronic Publication: 2025 Dec 05.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first